Brief: Taysha Gene Therapies Q2 Loss Per Share Of $1.09

Raisio Oyj

16/08/2021 12:38

Aug 16 (Reuters) - Taysha Gene Therapies Inc  TSHA.O :
    * TAYSHA GENE THERAPIES REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q2 LOSS PER SHARE $1.09
    * RAISIO OYJ - AS OF JUNE 30, 2021, TAYSHA HAD $197.4
MILLION IN
CASH AND CASH EQUIVALENTS

Source text for Eikon:  ID:nBwb7fvJ3a 
Further company coverage:  TSHA.O 

 ((Reuters.Briefs@thomsonreuters.com;))